Virus encoded circulatory miRNAs for early detection of prostate cancer
View/ Open
Author
Yun, Seok Joong
Kim, Wun-Jae
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/s12894-015-0111-9Metadata
Show full item recordCitation
Kim, Jayoung, Seok Joong Yun, and Wun-Jae Kim. 2015. “Virus encoded circulatory miRNAs for early detection of prostate cancer.” BMC Urology 15 (1): 116. doi:10.1186/s12894-015-0111-9. http://dx.doi.org/10.1186/s12894-015-0111-9.Abstract
Background: Prostate cancer (PCa) is the most commonly diagnosed cancer and kills about 28,000 American men annually. Although progress has been made in understanding the molecular features of different forms of the disease, PCa is considered incurable when it becomes resistant to standard therapies. Prostate specific antigen (PSA) test has been a gold standard of diagnosis for PCa, however, it can result in lead to the unnecessary biopsies and treatment of indolent cancers due to the low specificity. Thus, the limitations of PSA screening for PCa have prompted much focus on strategies how to enhance the accuracy of PSA for distinction between aggressive and indolent cancers. Discussion Studies of miRNAs in PCa patients have suggested differentially expressed miRNAs between healthy controls and those with PCa, providing potential biomarker candidates using body fluids including urine and blood. Virus infection has been considered to associate with PCa incidence. Virus infected PCa cells may shed extracellular vesicles and communicate with neighboring cells, which were not infected yet, however, no mechanistic approaches were performed to understand the biology. The miRNAs composition in the shedding extracellular vesicles, and its role in PCa are completely undefined. In the near future, new insights to connect between the viral derived miRNAs and PCa progression might provide an opportunity to diagnose, risk prediction and therapeutic strategies. Summary The goal of this debate article is to provide a short review on miRNAs, virus infection and viral encoded miRNAs in PCa, with a primary focus on circulating miRNAs as potential non-invasive biomarkers for PCa patients.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662007/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:23845206
Collections
- HMS Scholarly Articles [17920]
Contact administrator regarding this item (to report mistakes or request changes)